Genetic diversity of hepatitis B virus (HBV) in Madagascar by S.F. Andriamandimby et al.
For Peer Review
 
 
 
 
 
 
Genetic diversity of Hepatitis B Virus (HBV) in Madagascar 
 
 
Journal: Journal of Medical Virology 
Manuscript ID JMV-16-5204.R1 
Wiley - Manuscript type: Research Article 
Date Submitted by the Author: n/a 
Complete List of Authors: Andriamandimby, Soa Fy; Institut Pasteur of Madagascar, Virology Unit 
Lo Presti, Alessandra; Istituto Superiore di Sanita, Department of 
Infectious, Parasitic and Immunomediated Diseases, Epidemiology Unit, 
Reference Centre on Phylogeny, Molecular Epidemiology and Microbial 
Evolution (FEMEM) 
Lai, A.; University of Milan, Department of Clinical Sciences ‘L. Sacco’ 
Hospital, Section of Infectious Diseases and Immunopathology 
Olive, Marie-Marie; Institut Pasteur of Madagascar, Virology Unit 
Angeletti, Silvia; University Hospital Campus Bio-Medico, Rome, Italy, 
Clinical Pathology and Microbiology Laboratory 
De Florio, Lucia; University Hospital Campus Bio-medico, Clinical Pathology 
and Microbiology Laboratory 
Cella, Eleonora; Istituto Superiore di Sanità, Malattie Infettive 
Razafindramparany, Minoharimbola; Institut Pasteur de Madagascar, 
Virology Unit 
Ravalohery, Jean-Piere; Institut Pasteur de Madagascar, Virology Unit 
Andriamamonjy, Seta; Institut Pasteur de Madagascar, Virology Unit 
Gioffrè, Sonia; L. Sacco, University of Milan 
Zehender, Gianguglielmo; University of Milan, Department of Clinical 
Sciences-Infectious Diseases Section 
Mottini, Giovanni; University Hospital Campus Bio-medico 
Ciccozzi, Massimo; Istituto superiore di sanità, dipartimento di malattie 
infettive e immunomediate, reparto di epidemiologia;   
Heraud, Jean-Michel; Institut Pasteur de Madagascar, Virology 
Keywords: Hepatitis B virus < Virus classification, Epidemiology, Evolution 
  
 
 
John Wiley & Sons
Journal of Medical Virology
For Peer Review
1 
 
Genetic diversity of Hepatitis B Virus (HBV) in Madagascar 
Soa Fy Andriamandimby1#, Alessandra Lo Presti2#, Alessia Lai3, Marie-Marie Olive1, Silvia 
Angeletti4, Lucia De Florio4, Eleonora Cella2,5, Minoharimbola Razafindramparany1, Jean-
Piere Ravalohery1, Seta Andriamamonjy1, Sonia Gioffrè3, Gianguglielmo Zehender3, 
Giovanni Mottini6, Massimo Ciccozzi2,6*° and Jean-Michel Heraud1*. 
 
1 Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar 
2 Department of Infectious, Parasitic and Immunomediated Diseases, National Institute of 
Health, Rome, Italy; 
3 Department of Biomedical and Clinical Sciences ‘L. Sacco’, University of Milan, Milan, Italy; 
4 Clinical Pathology and Microbiology Laboratory, University Hospital Campus Bio-Medico of 
Rome, Rome, Italy; 
5 Public Health and Infectious Diseases, Sapienza University, Rome, Italy 
6 University Hospital Campus Bio-Medico, Rome, Italy. 
# These authors contributed equally 
* These authors contributed equally (co-senior authors)  
 
° Corresponding author: Prof. Massimo Ciccozzi, Department of Infectious, Parasitic and 
Immunomediated Diseases, National Institute of Health, Rome, Italy 
massimo.ciccozzi@iss.it 
 
Running head:  Hepatitis B Virus in Madagascar
Page 1 of 22
John Wiley & Sons
Journal of Medical Virology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
Abstract  
Hepatitis B virus (HBV) is a DNA virus belonging to Hepadnaviridae family. Chronic 
infection with HBV is one major risk factor of hepatic disease. In Madagascar, former studies 
classified the country as part of high endemic area, as HBV prevalence can reach 23% in 
general population. However, this prevalence differs largely between urban and rural areas 
and is estimated to be respectively 5% and 26%. The aims of the present study were to 
describe the genetic diversity of HBV strains from different regions of Madagascar, and to 
describe the viral gene flow throughout the country by using phylogenetic analysis. This is the 
first large-scale molecular and phylogenetic study analyzing HBV sequences from 28 
different Malagasy areas, never sampled in the past. In this study, the most prevalent 
genotype/sub-genotypes was E. Migration analysis showed a gene flow from zone 3 (rural) to 
zone 2 (suburban) and a greater gene flow from the middle part of Madagascar to the north 
than to the south. It is important to study the HBV infections in Madagascar and to monitor 
the potential spread of this viral strain inside this country. 
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INTRODUCTION 
Hepatitis B virus (HBV) is a DNA virus belonging to Hepadnaviridae family. At least 2 
billion people alive today have been infected with HBV and of these, it is estimated that 240 
million individuals are chronically infected with this virus [Ott et al., 2012]. Chronic infection 
with HBV is one major risk factor of hepatic disease, and may bring to liver cancer [Lavanchy 
et al., 2005]. Three levels of chronic HBV infection, as measured by the prevalence of HBs 
antigenemia, exist in the world: high (>8%), intermediate (2–8%), and low (< 2%) [Kew, 
1992]. 
HBV is characterised by high genetic variability. Indeed, during viral replication, the use of 
reverse transcriptase, characteristic of hepadnavirus, is responsible of this phenomenon as this 
polymerase lacks of reading proof activity. Therefore, ten genotypes were described and 
named A to J. Genotypes are segregated into subgenotypes which have distinct ethno-
geographic distribution [Zehender et al., 2014]. Recent study have hypothesised that HBV has 
been coexpanding and co-migrating with human population, then this distribution of 
subgenotypes might be the result of the main modern human migration [Paraskevis et al., 
2013]. 
Most of African countries have a high level of endemicity (chronical infection >8%). In these 
countries transmission occurs mainly during perinatal and childhood periods [Hou et al., 
2005]. In East Africa, genotype A is the most prevalent genotype, while in other parts of 
Africa, genotype E is mostly observed [Croagh et al., 2015]. Some studies have suggested a 
relatively recent introduction of genotype E into the general African population [Andernach et 
al., 2009; Forbi et al., 2010]. 
In Madagascar, former studies on epidemiology of HBV classified the country as part of high 
endemic area as HBV prevalence can reach 23% in general population [Migliani et al., 2000]. 
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However, this prevalence differs largely between urban and rural areas and is estimated to be 
respectively 5% and 26% [Boisier et al., 1996; Arivelo et al., 2011; Randriamahazo et al., 
2015]. Like other African countries, transmission occurs mainly during perinatal and 
childhood periods [Migliani et al., 2000]. Few studies report genotype diversity of HBV in 
Madagascar. Genotype E is the most prevalent according to Dupinay et al. [Dupinay et al., 
2010], followed by genotype A1 and D. Phylogenetic analyses of the genotype E strains 
showed a relationship with West African strains [Kramvis et al., 2005]. However, these 
studies were performed using limited samples from northern and north-western parts of 
Madagascar.  
The aims of the present study were (i) to describe the genetic diversity of HBV strains from 
different regions of Madagascar, and (ii) to describe the viral gene flow throughout the 
country. 
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MATERIALS AND METHODS 
Human samples 
A national cross-sectional serological survey from November 2011 to April 2012 and from 
October 2012 to May 2013 was conducted. A total of 28 different zones (urban or rural) 
distributed over 34 administrative Malagasy districts were included (Fig. 1A). Individuals 
were randomly selected and a total of 100 individuals were finally included in the study. After 
reading of the informed consent letter, written and oral consent was obtained from 
volunteering individuals. The study protocol, including informed consent procedure, was 
approved by the Malagasy competent authorities: the Malagasy Ethic National Committee 
(authorization N° 066/MSAMP/CE, 26th July 2011). After consent, volunteers were blood 
sampled and sera were stored in Nitrogen liquid in the field, then at -80°C at the Virology 
Unit at the Institute Pasteur of Madagascar until use. The age of the volunteers ranged from 
18 to 99 years with a median age of 35 (mean age of 37.6) with a sex-ratio of 0.97. Of the 
1,778 sera tested, 141 sera (7.9% and IC95% [6.7-9.3-]) were positive for HBs antigen using 
in-house ELISA. 
 
HBV DNA Extraction and Amplification by Means of Nested PCR 
After a first serological screening searching HBs antigen, total DNA was extracted from 
positive sera using the NucleoSpin® Dx Virus (Macherey-Nagel), according to the 
manufacturer’s instructions. Sequences of about 1,348 nucleotides were amplified using a 
previously described multiple nested PCR protocol in order to obtain the HBV polymerase (P) 
and surface antigen (PreS/S) sequences [Zehender et al., 2012]. Amplicons were then purified 
using QIAquick PCR Purification Kit® (QIAGEN) before preforming DNA sequencing. 
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HBV DNA Sequencing  
The three DNA fragments were sequenced bidirectionally using a BigDye Terminator Kit 
version 3.1 (Applied Biosystems), according to the manufacture’s instruction. The sequencing 
products were purified by precipitating 10 l in an ethanol/sodium acetate mixture. Finally, 
sequences were loaded into an automated DNA sequencer ABI PRISM_ 3130 XL Genetic 
Analyser (Applied Biosystem). The sequence assembly was performed with Sequencer 4.1.4 
program (Sequencher® sequence analysis software, Gene Codes Corporation, Ann Arbor, MI 
USA http://www.genecodes.com). The sequences will be submitted to GenBank after the 
acceptance of the manuscript. 
 
Phylogenetic Analysis 
Each of the 100 HBV P-PreS/S genes, strains from Madagascar, were submitted to NCBI 
Genotyping Tool (http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi) then to 
jumping profile Hidden Markov Model (jpHMM) (http://jphmm.gobics.de/submission_hbv) 
in order to quickly identify the genotype of the sequences. This preliminary analysis has 
allowed to identify  97 “pure” genotype isolates and three hypothetical recombinants. 
For the purpose of phylogenetic analysis three data sets were built. The first data set included 
187 HBV P-PreS/S genotype/subgenotype-specific reference sequences, downloaded from 
GenBank, and 97 HBV P-PreS/S strains from Madagascar, previously reported as “pure” 
genotype in both NCBI and jpHMM genotyping analysis. This data set was used to confirm 
the previous genotyping. The second data set included 79 HBV E genotype P-PreS/S strains 
and was used for gene flow analysis. The third data set included 187 HBV P-PreS/S 
genotype/subgenotype reference sequences and the three hypothetical recombinant sequences 
and was used to test the nature of recombinants in Malagasy strains. The sequences of the 
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three dataset were aligned by using Clustal W included in Bioedit [Hall, 1999; Ciccozzi et al., 
2014], followed by manual editing. 
The hierarchical likelihood ratio test (LRT) method implemented in Model-Test version 3.07, 
as already described [Posada and Crandall, 1998; Ciccozzi et al., 2013] was used to select the 
evolutionary model that best fitted the sequences data. The GTR+I+G model was selected for 
all the data set. The phylogenetic tree of the first dataset was reconstructed by using 
Maximum Likelihood analysis with FastTree 2.1 with the evolutionary model previously 
selected by ModelTest [Price et al., 2010]. The statistical robustness and reliability of the 
branching order within the phylogenetic tree was confirmed with the support values analysis 
(SH-like local support values >0.70). A Bayesian phylogenetic tree was reconstructed by 
means of Mr Bayes on the second data set [Huelsenbeck and Ronquist, 2001]. A Markov 
Chain Monte Carlo search was made for 15 x 10
6
 generations using tree sampling every 100
th
 
generation and a burn-in fraction of 25%. Statistical support for specific clades was obtained 
by calculating the posterior probability of each monophyletic clade, and a posterior consensus 
tree was generated after a 25 % burn-in. This tree was used as starting tree to perform the 
gene flow analysis. The possible presence of recombination among HBV strains was tested by 
using the Simplot (http://sray.med.som.jhmi.edu/SCRoftware/simplot/) and SplitsTree 
programs [Huson and Bryant, 2006]. 
 
Migration analysis (gene flow) 
The Mac Clade version 4 program (Sinauer Associates, Sunderland, MA) was used on the 
second data set to test viral gene in/out flow among distinct HBV subpopulations within 
different area in Madagascar, using a modified version of the Slatkin and Maddison test as 
described below [Slatkin and Maddison, 1989; Lo Presti et al., 2013]. Two gene flow analyses 
were performed. The first one was conducted according to three groups defined as zone 1, 2 
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and 3 (nearly urban, suburban and rural) (Fig. 1B). Firstly, Zone 1 (urban, n= 8) included the 
administrative communes of the former capitals of provinces, and administrative communes 
located at the edge of national routes which connect these main provinces. Zone 2 (suburban, 
n= 30) included the communes next to the districts of the capitals of provinces and the 
communes of the administrative-centre of each districts. Zone 3 (rural, n= 40) included the 
communes out of districts of capitals of provinces and out of administrative-centre of each 
district. The sequences were included in each zone according to their sampling location. The 
second gene flow analysis was conducted classifying the HBV genotype E strains into three 
groups (north, n= 31; middle, n= 22; south, n= 27) based on the sampling location of the 
strains in Madagascar (Fig. 1A). 
A one-character data matrix was obtained from the original data set by assigning to each 
taxon in the tree a one-letter code indicating its group of origin. Then, the putative origin of 
each ancestral sequence (i.e. internal node) in the tree was inferred by finding the most 
parsimonious reconstruction (MPR) of the ancestral character. The final tree-length, i.e. the 
number of observed migrations in the genealogy, was compared to the tree-length distribution 
of 10,000 trees, after random joining-splitting. 
Observed genealogies significantly shorter than random trees indicate the presence of 
subdivided populations with restricted gene flow. Specific migrations among different areas 
(character states) were traced with the State changes and stasis tool (Mac Clade software), 
which counts the number of changes in a tree for each pair-wise character state. When 
multiple MPRs were present (as in our data set), the algorithm calculated the average 
migration count over all possible MPRs for each pair. The resulting pair-wise migration 
matrix was then normalized, and a randomization test with 10,000 matrices obtained from 
10,000 random trees (by random joining-splitting of the original tree) was performed to assess 
the statistical significance of the observed migration counts. 
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RESULTS 
Genotype/subgenotype assignation 
The genotyping resulted by NCBI Genotyping Tool and jpHMM found 97 pure subtypes and 
three possible recombinant form. 
Maximum likelihood phylogenetic tree (Fig. 2), showed different statistically supported 
clades, corresponding to different HBV genotype/subgenotypes. The ML tree showed that 
three Malagasy strains were classified as subgenotype D2 (3%), twelve strains as subgenotype 
D7 (12%), seventy-nine strains as subgenotype E (79 %) and three Malagasy strains as 
subgenotype A1 (3%). Simplot and Splits Recombination analysis found three “putative” 
recombinant strains (3%) (Fig. 3 and 4). 
SplitsTree analysis showed that three sequences were unassigned, as reported in Figure 3. 
Bootscan analyses (Fig. 4, part A, B and C) classified the three strains labelled #17, #46 and 
#104 as recombinant D7/E, with a unique pattern of recombination and a single breakpoint.  
 
Migration fluxes 
The null hypothesis of panmixia (i.e., no population subdivision or complete intermixing of 
sequences from different geographic areas) was rejected by the randomization test 
(p<0.0001). 
Regarding the gene flow analysis performed by using the division in zone 1, 2 and 3 (urban, 
suburban and rural), most of the observed HBV-E genotype gene flow (80 %) was from zone 
3 (rural) to zone 2 (suburban) (Fig. 5 a). 
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The second gene flow analysis classifying the HBV-E detected according to their origin 
(North, middle and south), showed a 57.1 % of gene flow from center to north and  a 42.9 % 
of gene flow from  center  to south was also found (Fig. 5 b). 
 
DISCUSSION 
HBV is characterized by a high degree of genetic heterogeneity and a worldwide distribution. 
Madagascar is an endemic area for HBV and previous studies indicated that genotype E is the 
most prevalent [Dupinay et al., 2010], followed by genotype A1 and D. In this study, the 
authors showed circulation of different HBV strains, some of them genetically related to 
strains isolated in other West African countries (the most divergent genotype E strain was 
derived from Madagascar). Nevertheless, in this study, only few sequences were obtained 
from blood collected from few villages and cities located in the northern and northwestern 
part of the country. Thus, those observations might not reflect the pattern of HBV 
genotypic/sub-genotypic circulation in the entire country.  
The present study is the first large-scale molecular and phylogenetic study analyzing HBV 
sequences from 28 different Malagasy areas never sampled in the past. In addition, it 
represents an updated overview of the strains circulating in Madagascar. In this study, the 
most prevalent genotype/sub-genotypes was E in agreement with the previous articles 
[Dupinay et al., 2010]. Moreover most genotype D Malagasy strains were sub-genotype D7, 
as already found by Dupinay et al., 2010. Interestingly three D7/E recombinant forms has 
been described for the first time in Madagascar assuming a possible co-circulation of 
genotype E, the most prevalent genotype and genotype D7. However, as emergence of 
genotype E is relatively recent [Andernach et al., 2009], suggesting sexual intercourse as 
mode of transmission of this HBV genotype. Temporal and phylogeographic study of viruses 
will confirm or not this hypothesis. 
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Migration analysis showed a gene flow from zone 3 (rural) to zone 2 (suburban) and a greater 
gene flow from the middle part of Madagascar to the north than to the south. Seroprevalence 
studies showed firstly a of higher prevalence hepatitis B surface antigen (HBsAg) in rural area 
compared to urban area [Boisier et al., 1996]. It suggests a genomic flow from the more 
prevalent areas to the less prevalent ones reflecting the movement of the virus from chronic 
carriers in the general population. The largest gene flow from the highlands to the northern of 
the island may be explained: (i) by the invasion of this part during the Malagasy kingdom 
history, (ii) moreover, geographic accessibility of northern part of the island is easier than to 
the southern part, as the mountain chain at the south-west can play a key role as a natural 
barrier, (iii) the south part of the island is naturally dry with regular food shortages, therefore 
less attractive for people migration. Moreover the north of Madagascar (e.g. Nosy Be Island) 
is characteristic and visited by a lot of tourist during the summer season and a sentinel 
surveillance program can be useful to monitor the HBV flow in this area. A surveillance 
program could be important also because since 2004, the majority of European Union 
member states have introduced the vaccine, either as universal infant, universal newborn or 
universal adolescent. However, a number of countries from northern Europe had not 
introduced the vaccine into the routine program [Mereckiene et al., 2010]. At the end, a better 
characterization and monitoring of HBV infected individuals in Madagascar are crucial in 
order to understand the epidemiology and to assess the efficacy of prevention and therapy in 
controlling the epidemic. Hepatitis B vaccine is available and is part of recommended vaccine 
by Ministry of Health since 2002; nevertheless to date no study has evaluated the coverage of 
this vaccine amongst the community. Probably screening individuals at risk of acquiring 
hepatitis B would help in limiting the spread and public health repercussions of the virus in 
this country. Continuous suppression of HBV replication in individuals with advanced liver 
disease prolongs life, decreases the need for liver transplantation, and potentially reduces the 
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risk for hepatocarcinoma. To the light of these considerations, it is important to study the 
HBV infections in Madagascar and to monitor the potential spread of this viral strain inside 
this country. 
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Figure Legends 
Fig. 1A. Map of Madagascar describing the different zone defined as zone 1 (in grey) 
representing urban area, zone 2 (in blue) representing suburban area and zone 3 (in white) that 
includes all districts outside of the two other zones. Zone1 include the administrative 
communes of the former capital of provinces, and administrative communes located at the 
edge of national routes which connect these main provinces. Zone 2 include the communes 
next to urban zones and the communes of the administrative-centre of each districts of 
Madagascar. Zone 3 include the communes out of district of capital of provinces and out of 
administrative-centre of each district. B. Madagascar map describing the geographic location 
of sampling sites divided in north, middle and south. 
Fig. 2. Maximum Likelihood analysis of the first dataset. The tree was rooted by using the 
midpoint method. Branch lengths were estimated with the best fitting nucleotide substitution 
model according to a hierarchical likelihood ratio test, and were drawn to scale with the bar at 
the bottom indicating 0.03 nucleotide substitutions per site. One (*) along a branch represents 
significant statistical support for the clade subtending that branch (SH-like local support 
values >0.70).  The main supported clades are highlighted and reported in different colors.  
 
Fig. 3. Network computed with Splits Tree by using the Neighbor-net method. The network 
of the three Malagasy unassigned sequences is shown. The scale bar indicates 1% of 
nucleotide divergence. The three Malagasy isolates are highlighted with arrows. 
 
Fig. 4. Bootscanning plots implemented in Simplot software for the three Malagasy isolates 
labelled #17, #46 and #104 (Panel A, B and C). 
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Fig. 5 a. Maximum parsimony migration patterns of  HBV E genotype Malagasy isolates 
to/from different zone (1, 2 and 3: urban, suburban and rural) of Madagascar. The bubblegram 
shows the frequency of gene flow (migrations) to/from different zone, as the percentage of the 
total observed migrations estimated from the tree with a modified version of the Slatkin and 
Maddison test. The surface of each circle is proportional to the percentage of observed 
migrations given within the circle. b. Maximum parsimony migration patterns of  HBV E 
genotype Malagasy isolates to/from different groups/areas (north, center, south) of 
Madagascar. The bubblegram shows the frequency of gene flow (migrations) to/from 
different areas, as the percentage of the total observed migrations estimated from the tree with 
a modified version of the Slatkin and Maddison test. The surface of each circle is proportional 
to the percentage of observed migrations given within the circle. 
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Fig. 1A. Map of Madagascar describing the different zone defined as zone 1 (in grey) representing urban 
area, zone 2 (in blue) representing suburban area and zone 3 (in white) that includes all districts outside of 
the two other zones. Zone1 include the administrative communes of the former capital of provinces, and 
administrative communes located at the edge of national routes which connect these main provinces. Zone 2 
include the communes next to urban zones and the communes of the administrative-centre of each districts 
of Madagascar. Zone 3 include the communes out of district of capital of provinces and out of 
administrative-centre of each district. B. Madagascar map describing the geographic location of sampling 
sites divided in north, middle and south.  
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Fig. 2. Maximum Likelihood analysis of the first dataset. The tree was rooted by using the midpoint method. 
Branch lengths were estimated with the best fitting nucleotide substitution model according to a hierarchical 
likelihood ratio test, and were drawn to scale with the bar at the bottom indicating 0.03 nucleotide 
substitutions per site. One (*) along a branch represents significant statistical support for the clade 
subtending that branch (SH-like local support values >0.70).  The main supported clades are highlighted 
and reported in different colors.  
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Fig. 3. Network computed with Splits Tree by using the Neighbor-net method. The network of the three 
Malagasy unassigned sequences is shown. The scale bar indicates 1% of nucleotide divergence. The three 
Malagasy isolates are highlighted with arrows.  
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Fig. 4. Bootscanning plots implemented in Simplot software for the three Malagasy isolates labelled #17, 
#46 and #104 (Panel A, B and C).  
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Fig. 5 a. Maximum parsimony migration patterns of  HBV E genotype Malagasy isolates to/from different 
zone (1, 2 and 3: urban, suburban and rural) of Madagascar. The bubblegram shows the frequency of gene 
flow (migrations) to/from different zone, as the percentage of the total observed migrations estimated from 
the tree with a modified version of the Slatkin and Maddison test. The surface of each circle is proportional 
to the percentage of observed migrations given within the circle. b. Maximum parsimony migration patterns 
of  HBV E genotype Malagasy isolates to/from different groups/areas (north, center, south) of Madagascar. 
The bubblegram shows the frequency of gene flow (migrations) to/from different areas, as the percentage of 
the total observed migrations estimated from the tree with a modified version of the Slatkin and Maddison 
test. The surface of each circle is proportional to the percentage of observed migrations given within the 
circle.  
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